As lawmakers debate how much funding to provide FDA in 2016 and the drug and device user fees talks enter the substantive stages, millions of dollars gathered from previous user fee agreements sit in the Federal Treasury as a result of a previous legal glitch, industry representatives say. The law has since been fixed but lawmakers are still hesitant to free up the funds for FDA because doing so would count against the budget caps and require an offset, even...